DVHGF (Devonian Health Group) Common Stock : $21.69 Mil (As of Oct. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Devonian Health Group Common Stock?

Devonian Health Group's quarterly common stock declined from Apr. 2024 ($21.82 Mil) to Jul. 2024 ($21.76 Mil) and declined from Jul. 2024 ($21.76 Mil) to Oct. 2024 ($21.69 Mil).

Devonian Health Group's annual common stock increased from Jul. 2022 ($21.31 Mil) to Jul. 2023 ($22.21 Mil) but then declined from Jul. 2023 ($22.21 Mil) to Jul. 2024 ($21.76 Mil).

Devonian Health Group Common Stock Historical Data

The historical data trend for Devonian Health Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group Common Stock Chart

Devonian Health Group Annual Data

Trend

Jun15

Jun16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

Common Stock

Get a 7-Day Free Trial

14.09

16.13

21.31

22.21

21.76

Devonian Health Group Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Common Stock	Get a 7-Day Free Trial															21.66	22.13	21.82	21.76	21.69

Devonian Health Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Devonian Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (OTCPK:DVHGF) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

GSD:Canada

Address

360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1

Website

https://www.groupedevonian.com

Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

From GuruFocus

Devonian Announces the Closing of a $315,000 Private Placement and an Additional Loan of $500,000

By GlobeNewswire GlobeNewswire • 08-22-2019